Compare ARK Genomic Revolution ETF (ARKG) vs Bandwidth Inc (BAND) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Bandwidth Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while Bandwidth Inc trades at $75.48 (market cap $2.42B). Which is the better fit depends on your goals.
| ARKG | BAND | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $78.44 |
52-Week Low | $23.09 | $12.82 |
Market Cap | — | $2.42B |
Enterprise Value | — | $2.79B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Bandwidth (BAND) trades at $75.48, down 3.77% on the day, with strong technical momentum despite recent weakness. The stock shows bullish technical signals with 19 buy indicators versus 6 sell, while fundamentals reveal mixed performance with negative net income margins (-0.64%) but solid revenue growth to $753.82 million in 2025. Recent news highlights AI platform expansion and a $275 million convertible notes offering to fuel growth initiatives.
Outlook remains cautiously optimistic with 75% analyst buy ratings and an $85 high price target, though profitability challenges and elevated valuation metrics (EV/EBITDA 63.18) present risks. The upcoming Q2 2026 earnings report on July 29 will be crucial for validating the AI-driven growth narrative.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Bandwidth Inc
Bandwidth is a global communications software company. Its CPaaS platform allows enterprises to embed voice, messaging, and 911 emergency services directly into their software applications via robust APIs.
Read more on BAND →
